Trial intelligence / Profile preview

LEO 90100 aerosol foam vs calcipotriol + betamethasone dipropionate gel in psoriasis vulgaris

2013-004686-14Phase 3Completed

Sponsor
LEO Pharma
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of calcipotriol + betamethasone in plaque psoriasis (2 arms), sponsored by LEO Pharma. Primary endpoint: Treatment success. Started Jun 2015; status: completed.

02

Drugs

calcipotriol + betamethasone
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on 2013-004686-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004686-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call